-
Support NIH and AHRQ funding (2017)
Can't see the PDF preview? Access it here.
-
Compounding exception for allergy
The Federation of State Medical Boards (FSMB) recently published, for comment, a draft position statement on physician compounding. The draft states that physi…
-
SUPPORT H.R. 4662 – School-Based Asthma Management Program Act
Can't see the PDF preview? Access it here.
-
Advocacy Council Strike Force takes Capitol Hill by storm – Day 1
Every year, the College Advocacy Council’s (AC) “Strike Force” travels to Washington, D.C. to visit Congress. We coordinate with the Allergy …
-
Update on USP 797 and FDA Compounding Guidance
当我们开始新的一年,我们你ght this to be a good time to update you on the status of our efforts to preserve in-office compounding of allergen extracts. Th…
-
Limiting allergenic extract
The Advocacy Council has been alerted to an issue that seems to be involving more and more states – extremely low limits of allergenic extract (95165) un…
-
Another compounding threat to allergy patients
The FDA recently released Draft Guidance that will have a huge impact on allergy practices – if it is not revised.The Advocacy Council prepare…
-
DASH – personal meetings with 120 congressional offices
Dr. Meadows, Dr. Imbeau, and Congressman Tom Rice (R-SC7).Our Advocacy Council Strike Force descended on Washington, D.C. to lobby on May 11 and 12. The perfec…
-
What we’ve been fighting for – state by state
争取我们的权利提供病人with immunotherapy continues on. And we’re still out there, battling on your behalf, no matter what. So f…
-
The fight for affordable immunotherapy continues
We’ve been busy lately – stomping out harmful legislation in states, meeting with people in leadership roles to address our concerns in person, and…
-
What’s next in the defense against USP?
You really came through for the specialty. Your letters came flooding in and not only that, you asked what more you can do. You saw our joint stakeholder lette…
-
Update on USP (US Pharmacopeia)
The Advocacy Council of ACAAI has received several phone calls in response to a recent article about the allergy exemption to the USP compounding regulations. …
-
Summary of Novitas Medicare for Allergen Immunotherapy LCD L35759
Summary of Novitas Medicare LCD for allergen immunotherapy (LCD L35759), effective August 13, 2015. The Advocacy Council of the ACAAI (formerly the JCAAI…